M. Solèr

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

M. Solèr, Jonathan Matz, Robert G. Townley et al. · European Respiratory Journal · 2001 · 822 citations · Full text

Exercise capacity as a predictor of postoperative complications in lung resection candidates.

Chris T. Bolliger, Peter J. Jordan, M. Solèr et al. · American Journal of Respiratory and Critical Care Medicine · 1995 · 249 citations

Physical Activity, Interventional Pulmonology, Pulmonary Care +25

Pulmonary function and exercise capacity after lung resection

CT Bolliger, Peter J. Jordan, M. Solèr et al. · European Respiratory Journal · 1996 · 210 citations · Full text

Advanced Lung Disease, Physical Fitness, Exercise +15

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

Roland Buhl, M. Solèr, Jonathan Matz et al. · European Respiratory Journal · 2002 · 178 citations · Full text

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma

Roland Buhl, G. Hanf, M. Solèr et al. · European Respiratory Journal · 2002 · 157 citations · Full text